Revelation’s net income for the three months ended March 31, 2023 was $6.2 million, or $2.79 basic earnings per share and $1.96 diluted earnings per share, compared to a net loss of $6.6 million, or ...
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained ...
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”) announced today statistically significant results in a validated preclinical ...
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback